| RS2514049153 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514049229 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS2514050218 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514051953 |
SYNE4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 76, Autosomal recessive nonsyndromic hearing loss 76 |
| RS2514052002 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS2514054212 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 99, Dystonia 12 |
| RS2514054481 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514056258 |
ATP1A3
|
Health Risk |
Likely pathogenic |
— |
| RS2514065578 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514066639 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 12, Alternating hemiplegia of childhood 2 |
| RS2514066934 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514067613 |
PPP2R1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2514069098 |
CIC
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2514070512 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2514073477 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS2514074117 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Central core myopathy |
| RS2514074208 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514075131 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood 2 |
| RS2514075292 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 99, Inborn genetic diseases |
| RS2514079238 |
PPP2R1A
|
Health Risk |
Likely pathogenic |
Houge-Janssens syndrome 2, Houge-Janssens syndrome 2 |
| RS2514079611 |
ATP1A3
|
Health Risk |
Likely pathogenic |
ATP1A3-associated neurological disorder, Dystonia 12 |
| RS2514082917 |
CIC
|
Health Risk |
Pathogenic |
— |
| RS2514083605 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514084596 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2514085671 |
BCAT2
|
Health Risk |
Likely pathogenic |
— |
| RS2514088767 |
CPT1C
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 73, Hereditary spastic paraplegia 73 |
| RS2514090823 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514094817 |
PPP2R1A
|
Health Risk |
Pathogenic |
Houge-Janssens syndrome 2, Houge-Janssens syndrome 2 |
| RS2514101882 |
RYR1
|
Health Risk |
Likely pathogenic |
Centronuclear myopathy, Centronuclear myopathy |
| RS2514102015 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514103047 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS2514108449 |
BICRA
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2514109185 |
BICRA
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2514109782 |
BICRA
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2514110530 |
BICRA
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2514111647 |
BICRA
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2514111692 |
BICRA
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2514111941 |
BICRA
|
Health Risk |
Pathogenic |
— |
| RS2514112962 |
SLC25A42
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2514116435 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2514117907 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514126893 |
BICRA
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2514130905 |
BICRA
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS2514137674 |
BICRA
|
Health Risk |
Pathogenic |
— |
| RS2514138366 |
BICRA
|
Health Risk |
Likely pathogenic |
BICRA-related disorder, BICRA-related disorder |
| RS2514143868 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514144323 |
ETFB
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514144368 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514144391 |
ETFB
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514146143 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514146983 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514147270 |
CPT1C
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 73, Hereditary spastic paraplegia 73 |
| RS2514148216 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2514149162 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514149482 |
ETFB
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514149910 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514152673 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514153018 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514153129 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514155370 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514155556 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514155822 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514155878 |
FCHO1
|
Health Risk |
Pathogenic |
— |
| RS2514155999 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514156024 |
ETFB
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514156770 |
ARHGAP35
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2514156784 |
ARHGAP35
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2514157003 |
ARHGAP35
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2514159829 |
ARHGAP35
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2514161964 |
ARHGAP35
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2514162911 |
ARHGAP35
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2514163537 |
ARHGAP35
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2514169709 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2514176735 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514176950 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514176987 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514177181 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514177448 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514177715 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514177898 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS2514178001 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514178269 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514192810 |
GP6
|
Health Risk |
Pathogenic |
— |
| RS2514210823 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514212793 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514214514 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514215278 |
U2AF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental delay |
| RS2514215337 |
U2AF2
|
Health Risk |
Likely pathogenic |
Leukodystrophy, Leukodystrophy |
| RS2514219045 |
U2AF2
|
Health Risk |
Pathogenic |
Developmental delay, dysmorphic facies |
| RS2514223066 |
CNOT3
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2514225496 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514227330 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514232982 |
SCN1B
|
Health Risk |
Pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2514232999 |
SCN1B
|
Health Risk |
Pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2514233130 |
SCN1B
|
Health Risk |
Pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2514234475 |
SCN1B
|
Health Risk |
Pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2514234786 |
SCN1B
|
Health Risk |
Pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2514235154 |
ARHGAP35
|
Health Risk |
Pathogenic |
Unilateral microphthalmos, Unilateral microphthalmos |
| RS2514235402 |
ARHGAP35
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Irido-corneo-trabecular dysgenesis |
| RS2514235517 |
SCN1B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 52 |